로딩 중…
지수 로딩 중…
Fulgent Genetics, Inc.
FLGT· NASDAQ· Health Care· Health Care Equipment & Services
$17.61+6.40%
2026-08-03
Financials
Valuation Metrics
Fulgent Genetics, Inc.'s Market Cap is $500M. At end of 2025 it was $809M. Ranked #2804 of 3,112 in US market (top 90%), #1222 of 1,445 on NASDAQ (top 85%), #170 of 206 in Health Care Equipment & Services (top 83%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $500M | US#2,804/3,112 Sec#170/206 |
| Revenue | $324M | US#2,521/3,112 Sec#157/206 |
| Net Income | $-84M | US—/3,112 Sec—/206 |
| Total Assets | $1.09B | US#2,414/3,112 Sec#125/206 |
| Net Assets | $1.00B | US#1,775/3,112 Sec#95/206 |
| Value | ||
| P/B | 0.50x | US#64/3,112 Sec#4/206 |
| P/S | 1.54x | US#998/3,112 Sec#69/206 |
| FCF Yield | -20.75% | US—/3,112 Sec—/206 |
| Profitability | ||
| ROE | -8.42% | US#2,377/3,112 Sec#132/206 |
| ROA | -7.75% | US#2,598/3,112 Sec#149/206 |
| Op. Margin | -35.79% | US#2,746/3,112 Sec#177/206 |
| Revenue Growth | 4.38% | US#1,808/3,112 Sec#136/206 |
| Financial Health | ||
| Debt Ratio | 9.31% | US#97/3,112 Sec#5/206 |
| Total Debt | $482000.00 | US#2,953/3,112 Sec#200/206 |
| FCF | $-104M | US#2,595/3,112 Sec#191/206 |
| Cash | $26M | US#2,800/3,112 Sec#189/206 |
| Current Ratio | 6.34x | US#378/3,112 Sec#27/206 |
| Performance | ||
| 1Y Return | -4.96% | US#2,197/3,112 Sec#152/206 |
| 1M Return | -15.54% | US#2,835/3,112 Sec#189/206 |
| From 52W High | -43.27% | US#2,630/3,112 Sec#175/206 |
| 1Y MDD | -55.30% | US#2,591/3,112 Sec#157/206 |
| Trading | ||
| Volume | 504,111 shares | US#2,066/3,112 Sec#153/206 |
| Trading Value | $9M | US#2,399/3,112 Sec#161/206 |
| Per Share | ||
| EPS | $-1.97 | US—/3,112 Sec—/206 |
| BPS | $36.13 | US#687/3,112 Sec#47/206 |